ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.683,73
-0,44%
S&P 500
5.308,13
0,09%
Dow Jones
39.806,77
-0,49%
Euro vs US Dollar
1,08611
0,01%
Bitcoin
70.926,77
-0,73%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NYSE
  6. Stevanato Group SpA (STVN)

  7. Stevanato Group SpA (STVN) News

STVN

Stevanato (STVN)

Stevanato Group SpA
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NYSE:STVN
DatumZeitQuelleÜberschriftSymbolFirma
20/05/202422h37Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNYSE:STVNStevanato Group SpA
16/05/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
14/05/202422h40Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
09/05/202422h10Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
09/05/202412h39Business WireStevanato Group Reports Financial Results for the First Quarter of 2024NYSE:STVNStevanato Group SpA
01/05/202422h30Business WireStevanato Group to Present at the Bank of America Securities Healthcare ConferenceNYSE:STVNStevanato Group SpA
25/04/202422h04Business WireStevanato Group to Report First Quarter 2024 Financial Results on May 9, 2024NYSE:STVNStevanato Group SpA
04/04/202414h00Business WireStevanato Group appoints Ugo Gay as Chief Operations OfficerNYSE:STVNStevanato Group SpA
26/03/202421h10Business WireStevanato Group Announces Closing of Upsized Public Offering of Ordinary Shares and Exercise in Full of the Underwriters’ Option to Purchase Additional Ordinary SharesNYSE:STVNStevanato Group SpA
22/03/202404h45Business WireStevanato Group Announces Pricing of Upsized Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
20/03/202422h12Business WireStevanato Group Announces Public Offering of Ordinary SharesNYSE:STVNStevanato Group SpA
11/03/202422h05Business WireStevanato Group to Present at the KeyBanc Capital Markets Virtual Life Sciences & MedTech Investor ForumNYSE:STVNStevanato Group SpA
07/03/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
07/03/202422h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
07/03/202412h30Business WireStevanato Group Delivers Double-Digit Revenue Growth in Fiscal Year 2023NYSE:STVNStevanato Group SpA
22/02/202422h30Business WireStevanato Group to Report Fourth Quarter and Year End 2023 Financial Results on March 7, 2024NYSE:STVNStevanato Group SpA
24/01/202414h00Business WireStevanato Group Launches EZ-fill® Kit and Laboratory Fill and Finish Service to Support Small Batch Drug Development and CommercializationNYSE:STVNStevanato Group SpA
03/01/202422h30Business WireStevanato Group to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNYSE:STVNStevanato Group SpA
16/11/202312h00Business WireStevanato Group's Mavis™ Combi Visual Inspection Machine Selected as Pharma Innovation Award Winner by Pharma ManufacturingNYSE:STVNStevanato Group SpA
09/11/202322h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
09/11/202312h30Business WireStevanato Group to Present at the Jefferies London Healthcare ConferenceNYSE:STVNStevanato Group SpA
03/11/202321h00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
31/10/202316h58Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
31/10/202316h45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
31/10/202311h30Business WireStevanato Group Reports Third Quarter 2023 Financial ResultsNYSE:STVNStevanato Group SpA
19/10/202322h30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
17/10/202322h05Business WireStevanato Group to Report Third Quarter 2023 Financial Results on October 31, 2023NYSE:STVNStevanato Group SpA
06/10/202323h29Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
05/10/202322h05Business WireStevanato Group Announces Voting Results from its Extraordinary General MeetingNYSE:STVNStevanato Group SpA
28/09/202315h31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NYSE:STVNStevanato Group SpA
 Showing the most relevant articles for your search:NYSE:STVN

Kürzlich von Ihnen besucht

COIN
EBCBTC
eBullionCoin
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten